Related Articles
DL‑3‑n‑butylphthalide therapy for Parkinson's disease: A randomized controlled trial
Clinical correlation of peripheral CD4+‑cell sub‑sets, their imbalance and Parkinson's disease
New‑onset non‑motor symptoms in patients with Parkinson's disease and post‑COVID‑19 syndrome: A prospective cross‑sectional study
Potential use of glutathione as a treatment for Parkinson's disease
Effects of pramipexole treatment on the α-synuclein content in serum exosomes of Parkinson's disease patients